search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
COAGULATION


Innovative haemostasis systems: a solution for routine and special testing


First launched in Japan, the CN-Series of analysers from Sysmex has now undergone multi-centre validation and verification work in the UK ahead of global introduction in 2021. Here, the company introduces the equipment and its various hardware and software features.


When it comes to the pace of product development and the introduction of new, innovative analysers, few diagnostic companies can match the record of Sysmex. Across the business fields of haematology, haemostasis and urinalysis, the company has a history of annual product releases that have each raised the bar for the discipline concerned. It will be the turn of haemostasis in 2021 to see a new platform in the shape of the CN-Series. Previewed at the 2020 International Society on Thrombosis and


Haemostasis (ISTH) Virtual Congress, the CN-Series offers new hardware, improved software and the introduction to haemostasis testing of the tracked workcell concepts pioneered by Sysmex haematology systems, and will give users new options in maximising the performance of their service.


Introducing the CN-Series The CN-Series includes two models, the CN-3000 and CN-6000, to ensure that laboratories of any size are catered for


with a solution that meets their throughput requirements and size constraints. Both systems, identical in size and shape, have a smaller footprint than the current Sysmex CS-5100 analysers.


For hub laboratories, the CN-6000


provides a throughput of 450 samples per hour when running prothrombin (PT) samples and 401 per hour running PT and activated partial thromboplastin time (APTT) samples. Up to three CN-6000 analysers can be linked to a common loading bay by a track system. This allows haemostasis laboratories to access the proven workflow benefits that the Sysmex XN-Series has delivered to haematology for many years.


CN-Series with extended sampler (left), allows for a workload capacity of 120 samples at any one time. Standalone CN-Series (right), allows for a workload capacity of up to 30 samples.


WWW.PATHOLOGYINPRACTICE.COM DECEMBER 2020


A single point of entry for samples to be sent to all three analysers is combined with intelligent sample routing that knows what tests are available on each connected system. Tubes are then sent to the next available CN-Series analyser, ensuring that each system works to its maximum capacity and that turnaround times are minimised. Automated re-run and reflex testing minimises user involvement so that staff are free for more valuable tasks, rather than spending time moving racks between analysers. The reliability of the Sysmex track, together with innovative components like turn units, means that ‘island’ automation is, for the first time, a realistic option for large haemostasis laboratories. An advanced, market-tested sample integrity checking system ensures the quality of sample results without manual intervention – a key feature for a successful workcell concept. Both sample volume and haemolysis, icterus and lipaemia (HIL) checking are performed and HIL limits are assay specific. The system includes Automatic Switching of Detection Sensitivity (ASDS) for reduced assay interference, allowing the system to


39


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62